Citadel Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Citadel Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-65,900	Closed	-$11.4M	–	9485
2015 Q1	$11.4M	Sell	65,900 -23,600	-26%	-$3.46M	0.01%	1347
2014 Q4	$10.3M	Buy	89,500 +10,000	+13%	+$1.21M	0.01%	1378
2014 Q3	$12.4M	Buy	79,500 +4,000	+5%	+$580K	0.01%	1216
2014 Q2	$9.31M	Buy	75,500 +36,900	+96%	+$4.08M	0.01%	1318
2014 Q1	$4M	Buy	38,600 +21,400	+124%	+$2.19M	﹤0.01%	1977
2013 Q4	$1.55M	Sell	17,200 -2,800	-14%	-$223K	﹤0.01%	2797
2013 Q3	$1.34M	Buy	20,000 +1,500	+8%	+$103K	﹤0.01%	2800
2013 Q2	$1.22M	Buy	+18,500	New	+$1.06M	﹤0.01%	2984

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Citadel Advisors's SLXP Position: Q2 2015 in Review

Citadel Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 14,386 shares — an estimated $2.49M sold.

Citadel Advisors first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $154M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Citadel Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Citadel Advisors sold 14,386 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $2.49M.
Citadel Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Citadel Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $154M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.